Comprehensive Emergency Medicine Study Notes (Transcript)

Acute Coronary Syndrome (ACS) and Myocardial Infarction (MI)

• Presentation clues discussed: chest pain and possible heart attack (myocardial infarction).
• The four classic acute MI pharmacologic interventions (MONA) mentioned: Morphine, Oxygen, Nitroglycerin, and Aspirin. There is debate about strict order; the transcript notes that they are not strictly bound to one fixed order in practice.
  • MONA components:
  • Morphine
  • Oxygen
  • Nitroglycerin
  • Aspirin
  • In practice, order can vary depending on patient status (e.g., oxygen for hypoxemia; aspirin given early; nitroglycerin as long as blood pressure allows; morphine for persistent pain).
• Types of myocardial infarction on ECG:
  • STEMI: ST-segment elevation on EKG indicates a transmural infarction with acute occlusion.
  • NSTEMI: non–ST elevation myocardial infarction; ST segments not elevated but enzymes (troponin) are elevated.
  • Transcript prompts recall of PQRST waves and the concept that elevated ST is a hallmark of STEMI; elevated T waves mentioned as a partial cue.
• Pathophysiology:
  • Blockage of coronary blood flow → ischemia and myocardial injury; poor perfusion leads to decreased oxygen delivery to the myocardium.
• Diagnostic tests:
  • Cardiac enzymes (troponins) to detect myocardial injury.
  • 12-lead ECG to identify ST elevation or depression and other changes.
  • EKG reference: PQRST waves; ST elevation indicates STEMI; non-elevated ST suggests NSTEMI.
• Management and treatment options:
  • Acute MI is a medical emergency requiring rapid reperfusion.
  • Reperfusion strategies include PCI with stent placement or CABG (coronary artery bypass graft).
  • Other supportive care includes antiplatelet therapy (e.g., aspirin) and antianginal/vasodilator strategies when appropriate.
  • The transcript mentions a “stent” and “bypass” as surgical options; the mnemonic MONA is used as a teaching aid for initial management.
  • Concept of myocardial perfusion: restoring blood flow to relieve ischemia and preserve viable myocardium.

Pneumonia

• Pneumonia is described as a lung infection.
• At-risk population highlighted: geriatric patients.
• General clinical emphasis: recognize infection in the lungs and manage accordingly (antibiotics, supportive care, and assessment of respiratory status).

Bronchospasm, COPD, and Asthma

• Bronchospasm: bronchial constriction leading to reduced airway diameter and difficulty breathing. Causes include inflammation and underlying diseases such as COPD; allergic or infectious triggers may contribute.
• COPD (Chronic Obstructive Pulmonary Disease):
  • Common feature: chronic hypoxemia with lower oxygen saturation; reference given as around or below 88% in some patients.
  • Terminology: barrel-chested appearance referenced (typical of emphysema phenotype).
• Asthma:
  • Pathophysiology: bronchoconstriction and narrowing of the bronchioles, leading to wheezing and difficulty with expiration.
  • Treatment: bronchodilators such as albuterol (a beta-agonist) used to relieve bronchospasm.
  • Auscultation: expiratory wheeze is typical; expiratory phase is when wheezing is often most evident.
  • Acute asthma exacerbation progress: rapid improvement after treatment is concerning if the patient suddenly looks much better; risk of status asthmaticus if the patient improves too much or too quickly is discussed as a potentially dangerous scenario.
  • Status asthmaticus is a medical emergency requiring urgent escalation of care.

Systemic Infection, Sepsis, and Shock

• Sepsis/systemic infection indicators discussed: confusion, shortness of breath, abnormal blood pressure (variability between low and high readings discussed), and fever may be present.

• Common laboratory workup in suspected sepsis:

  • ABG (arterial blood gas)
  • CBC (complete blood count)
  • Platelet count discussed as part of coagulopathy assessment
  • Lactate level is a key marker for tissue hypoperfusion and severity of sepsis

• Initial management of sepsis/shock:

  • Fluids: intravenous fluids (commonly crystalloid; e.g., lactated Ringer’s or normal saline) are given to restore circulation.
  • Antibiotics: broad-spectrum antibiotics as soon as sepsis is suspected.
  • Oxygen: supplemental oxygen to maintain adequate oxygen delivery.
  • Vasopressors if refractory to fluids to maintain mean arterial pressure (MAP): common agents include epinephrine and norepinephrine.

• Complications of sepsis discussed:

  • DIC (Disseminated Intravascular Coagulation)
  • MODS (Multiple Organ Dysfunction Syndrome) as a possible progression if sepsis is not controlled.

• Fluids and hemodynamics notes:

  • In hypotensive, hypovolemic patients, fluid resuscitation aims to achieve stable blood pressure and adequate perfusion.
  • If fluids are insufficient to maintain perfusion, vasopressors (vasoconstrictors) are used to increase vascular tone and blood pressure.

• Two key vasopressors named: Epinephrine and Norepinephrine (nor-epinephrine).

Deep Vein Thrombosis (DVT) Prophylaxis and Mobility

• Risk factors: immobility and post-operative status discussed; inability to ambulate increases DVT risk.
• Non-pharmacologic prophylaxis:
  • Compression devices: Sequential Compression Devices (SCDs) to promote venous return.
  • Encouraging ambulation and leg movements (e.g., ankle flexion) to promote circulation.
  • Elevation of legs when appropriate.
• Pharmacologic prophylaxis:
  • Heparin or low-molecular-weight heparin (LMWH, e.g., Lovenox) as prophylaxis.
  • Warfarin is mentioned as a possible option depending on clinical context.
  • Intermittent use of compression devices and pharmacologic prophylaxis depending on bleeding risk and surgical status.
• Device care:
  • Skin checks and patient safety: ensure no skin breakdown under compression devices; remove and recheck regularly.
• Postoperative considerations:
  • For patients with lower-extremity surgery, DVT prophylaxis is particularly emphasized.

Oxygen Therapy and COPD Considerations

• Oxygen delivery options:

  • Nasal cannula: maximum delivery around $6 \,\text{L/min}$.
  • Non-rebreather mask: delivers approximately $6-12 \,\text{L/min}$, sometimes up to ~$15 \,\text{L/min}$.
  • High-flow nasal cannula as an alternative in more severe cases.

• COPD considerations in oxygen therapy:

  • Avoid giving 100% oxygen to COPD patients because they are CO2 retainers; high oxygen can blunt the respiratory drive and worsen CO2 retention.
  • Target oxygen saturation in COPD is typically $88\%\text{ to }92\%$ to avoid CO2 narcosis and respiratory acidosis.

• General oxygen concepts:

  • Oxygen delivery must consider airway pressures and patient condition rather than simply maximizing FiO2.

Tuberculosis (TB)

• Transmission: airborne infection.
• Diagnostic approach:
  • Chest X-ray can show typical findings.
  • Microbiological testing includes culture and acid-fast bacilli (AFB) smear, and nucleic acid amplification tests.
  • PPD (tuberculin skin test) is sometimes used in screening but may take time to read; culture and AFB are more definitive for active disease.
• Household exposure:
  • If someone in the household tests positive for TB, educate the patient about transmission risks and follow-up testing.

Glaucoma: Open-Angle vs. Closed-Angle

• Intraocular pressure (IOP): normal around approximately $20\text{ mmHg}$.
• Open-angle glaucoma:
  • Described as a slower, gradual process of optic neuropathy due to chronic open angle.
• Closed-angle glaucoma:
  • Acute, rapid onset due to sudden blockage of aqueous humor outflow; urgent treatment required.

Transfusion Medicine and IV Lines

• Normal saline flushing after blood transfusion:
  • After stopping a transfusion due to suspected reaction, flush the line with normal saline to clear remaining product from the line; disconnect tubing and manage the IV catheter to prevent further transfusion of the problematic product.
• Premedication for suspected transfusion reactions (described in the transcript):
  • Acetaminophen (Tylenol) and diphenhydramine (Benadryl).
  • Sometimes an intranasal decongestant such as oxymetazoline (Afrin) is mentioned, though this is not standard practice for all transfusion reactions.
• Practical considerations:
  • Determine the sequence of actions in transfusion reactions and ensure patient safety; stopping transfusion is the priority, followed by assessment and treatment of reaction symptoms.

Anemias: Types and Key Features

• Pernicious anemia:

  • Vitamin B12 deficiency due to lack of intrinsic factor, leading to impaired B12 absorption.
  • Treatment typically requires parenteral B12 (cyanocobalamin or hydroxocobalamin) injections rather than oral B12 alone.

• Aplastic anemia:

  • Bone marrow failure leading to pancytopenia (reduction in RBCs, WBCs, and platelets).
  • Symptoms include weakness, increased infection risk, and bleeding tendency.

• Pancytopenia:

  • Decreased red cells, white cells, and platelets.
  • Education for patients includes infection prevention, bleeding precautions, and regular monitoring.

• Patient education points for pancytopenia include:

  • Avoid crowds and high-risk environments to reduce infection risk.
  • Practice strict hand hygiene and food safety (avoid unpasteurized products, handling raw foods with care).
  • Daily temperature monitoring to catch fevers early.
  • Bleeding precautions and avoidance of activities with high bleeding risk.
  • Consideration of transfusion or growth factor support as indicated by clinical status.

Diet and Cardiac/Liver/Kidney Considerations

• Heart failure and diet:
  • Advice to limit sodium intake; sodium-restricted diet helps reduce edema and fluid overload.
  • In some guidelines, potassium-rich foods are discussed; however, in specific cardiac and renal contexts, potassium intake should be individualized.
• Organ involvement in left-sided heart failure:
  • Kidney and liver involvement can occur due to chronic congestion and reduced perfusion.
• Isoelectric line (EKG baseline concept):
  • The isoelectric line is the baseline reference on an EKG from which deviations (ST, T wave, QRS changes) are measured.
  • The concept helps interpret whether ST segments are elevated or depressed relative to this baseline.

Electrical Therapy: Defibrillation and CPR Essentials

• Defibrillable rhythms:
  • Ventricular tachycardia with no pulse (pulseless VT) and ventricular fibrillation (VF) are defibrillatable rhythms.
  • The characteristic “tombstone” EKG pattern is sometimes used in discussions of acute STEMI; the transcript mentions a tombstone-like appearance in certain contexts of ST elevation, but the main actionable distinction is pulseless VT and VF as defibrillatable.
• When to shock and when not to shock:
  • If the patient has no pulse and is unresponsive, immediate defibrillation is indicated for pulseless VT/VF following CPR initiation.
  • If the patient has a pulse but is unresponsive or not breathing, do not shock; manage with airway, breathing, and circulation (adriven by BLS guidelines).
• CPR guidelines discussed:
  • High-quality CPR saves lives.
  • If unresponsive and not breathing but pulse is absent, begin CPR with chest compressions and rescue breaths.
  • If there is a pulse but no effective breathing, focus on providing breaths and airway support rather than chest compressions.
  • BLS standard: 30 compressions to 2 ventilations (30:2) for adults during cardiac arrest when no advanced airway is in place.
• In-hospital CPR nuance:
  • Avoid performing CPR on a patient with a normal rhythm and a stable pulse unless indicated by a specific reversible cause or procedure (e.g., thrombectomy for stroke); resuscitation decisions should be guided by documentation, goals of care, and clinical context.
• Practical notes on CPR dynamics:
  • If a patient is on a pacemaker or has a rhythm with a pulse, do not perform chest compressions; instead, optimize oxygenation, airway, and perfusion.
  • When a person may have a reversible cause or require airway management, intubation and advanced interventions may be pursued.
  • In the hospital, there are nuanced decisions about whether to shock, intubate, or pursue thrombectomy based on rhythm, pulse, and the underlying cause of arrest (e.g., stroke or PE).

Quick Reference Summary (Key Practical Takeaways)

• ACS management can be summarized with MONA, but practice varies by patient status and guidelines; early aspirin and definitive reperfusion are critical.
• STEMI requires rapid reperfusion (PCI or CABG); NSTEMI is managed with anti-ischemic therapy and risk stratification, with coronary intervention as indicated.
• Oxygen therapy should be titrated; COPD patients often target SpO2 ~$88\%-92\%$ to avoid CO2 retention.
• DVT prevention combines mobility, compression devices, and pharmacologic prophylaxis (heparin/LMWH; warfarin as appropriate).
• Sepsis management includes early fluids, antibiotics, oxygen, and vasopressors if needed; monitor lactate and CBC/ABG to guide therapy; watch for DIC and MODS.
• TB diagnosis relies on culture and acid-fast testing; PPD has limitations for active TB diagnosis.
• Glaucoma management hinges on recognizing open-angle (gradual) vs closed-angle (acute) presentations; IOP ~$20\text{ mmHg}$ is a reference baseline.
• Anemia types require targeted therapy: pernicious anemia (B12 injections), aplastic anemia (bone marrow failure), and pancytopenia (low RBCs, WBCs, platelets) with infection/bleeding precautions.
• Transfusion reactions require stopping the transfusion, flushing the line with saline, and premedication in some cases (acetaminophen, diphenhydramine); ensure safe IV management.
• CPR basics emphasize high-quality CPR; do not defibrillate a patient with a pulse; use 30:2 timing unless an advanced airway is in place; consider reversible etiologies and advanced interventions.
• Nutritional and organ considerations: heart failure patients benefit from sodium restriction; monitor kidney and liver involvement in left-sided heart failure.
• Important numeric/dose references throughout: discuss exact flows and rates as needed in clinical context, e.g., nasal cannula up to $6\,\text{L/min}$, non-rebreather up to $12-15\,\text{L/min}$, target SpO2 $88\%-92\%$ in COPD, urine output minimum > 30\,\text{mL/h}, and normal IOP baseline around $20\text{ mmHg}$.